These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 9550413

  • 1. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
    Wizel B, Nunes M, Tarleton RL.
    J Immunol; 1997 Dec 15; 159(12):6120-30. PubMed ID: 9550413
    [Abstract] [Full Text] [Related]

  • 2. Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL.
    Low HP, Santos MA, Wizel B, Tarleton RL.
    J Immunol; 1998 Feb 15; 160(4):1817-23. PubMed ID: 9469442
    [Abstract] [Full Text] [Related]

  • 3. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X, Yonemitsu Y, Chou B, Yoshida K, Tanaka S, Hasegawa M, Tetsutani K, Ishida H, Himeno K, Hisaeda H.
    Vaccine; 2009 Oct 19; 27(44):6154-9. PubMed ID: 19712768
    [Abstract] [Full Text] [Related]

  • 4. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA, Claser C, de Alencar BC, Tzelepis F, de Vasconcelos JR, de Oliveira G, Silvério JC, Machado AV, Lannes-Vieira J, Bruna-Romero O, Gazzinelli RT, dos Santos RR, Soares MB, Rodrigues MM.
    Vaccine; 2009 Sep 18; 27(41):5644-53. PubMed ID: 19635607
    [Abstract] [Full Text] [Related]

  • 5. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
    Chou B, Hiromatsu K, Hisaeda H, Duan X, Imai T, Murata S, Tanaka K, Himeno K.
    Biochem Biophys Res Commun; 2010 Feb 12; 392(3):277-82. PubMed ID: 20059980
    [Abstract] [Full Text] [Related]

  • 6. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
    Buckner FS, Wipke BT, Van Voorhis WC.
    Eur J Immunol; 1997 Oct 12; 27(10):2541-8. PubMed ID: 9368608
    [Abstract] [Full Text] [Related]

  • 7. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
    Nickell SP, Stryker GA, Arevalo C.
    J Immunol; 1993 Feb 15; 150(4):1446-57. PubMed ID: 8432987
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family.
    Santos MA, Garg N, Tarleton RL.
    Mol Biochem Parasitol; 1997 May 15; 86(1):1-11. PubMed ID: 9178263
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN, Castelo-Branco MT, Lannes-Vieira J, Gattass CR.
    Exp Parasitol; 1999 Jan 15; 91(1):7-19. PubMed ID: 9920038
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
    Martin D, Tarleton R.
    Immunol Rev; 2004 Oct 15; 201():304-17. PubMed ID: 15361249
    [Abstract] [Full Text] [Related]

  • 15. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.
    Wizel B, Palmieri M, Mendoza C, Arana B, Sidney J, Sette A, Tarleton R.
    J Clin Invest; 1998 Sep 01; 102(5):1062-71. PubMed ID: 9727076
    [Abstract] [Full Text] [Related]

  • 16. The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic.
    Millar AE, Wleklinski-Lee M, Kahn SJ.
    J Immunol; 1999 May 15; 162(10):6092-9. PubMed ID: 10229851
    [Abstract] [Full Text] [Related]

  • 17. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.
    Wizel B, Garg N, Tarleton RL.
    Infect Immun; 1998 Nov 15; 66(11):5073-81. PubMed ID: 9784506
    [Abstract] [Full Text] [Related]

  • 18. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
    Katae M, Miyahira Y, Takeda K, Matsuda H, Yagita H, Okumura K, Takeuchi T, Kamiyama T, Ohwada A, Fukuchi Y, Aoki T.
    Infect Immun; 2002 Sep 15; 70(9):4833-40. PubMed ID: 12183527
    [Abstract] [Full Text] [Related]

  • 19. Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.
    Tzelepis F, de Alencar BC, Penido ML, Gazzinelli RT, Persechini PM, Rodrigues MM.
    Infect Immun; 2006 Apr 15; 74(4):2477-81. PubMed ID: 16552083
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.
    Vaccine; 2015 Mar 03; 33(10):1274-83. PubMed ID: 25625671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.